Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem.
Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem.
复制标题
DOI:
10.3390/biomedicines9121915
复制
发表时间:
2021-12-14
期刊:
影响因子:
4.7
通讯作者:
Gual P
中科院分区:
文献类型:
--
作者:
Le Garf S;Nègre V;Anty R;Gual P
Metabolic-associated fatty liver disease (MAFLD), previously called nonalcoholic fatty liver diseases (NAFLD), is one of the most important causes of chronic liver disease worldwide and will likely become the leading cause of end-stage liver disease in the decades ahead. MAFLD covers a continuum of liver diseases from fatty liver to nonalcoholic steatohepatitis (NASH), liver fibrosis/cirrhosis and hepatocellular cancer. Importantly, the growing incidence of overweight and obesity in childhood, 4% in 1975 to 18% in 2016, with persisting obesity complications into adulthood, is likely to be harmful by increasing the incidence of severe MAFLD at an earlier age. Currently, MAFLD is the leading form of chronic liver disease in children and adolescents, with a global prevalence of 3 to 10%, pointing out that early diagnosis is therefore crucial. In this review, we highlight the current knowledge concerning the epidemiology, risk factors and potential pathogenic mechanisms, as well as diagnostic and therapeutic approaches, of pediatric MAFLD.
登录
查看更多内容
影响因子:
24.5
作者:
Feldstein AE;Charatcharoenwitthaya P;Treeprasertsuk S;Benson JT;Enders FB;Angulo P
通讯作者:
Angulo P
影响因子:
3.8
作者:
Carriere, Caroline;Thibault, Helene;Tauber, Maithe
通讯作者:
Tauber, Maithe
影响因子:
11.1
作者:
Dongiovanni P;Stender S;Pietrelli A;Mancina RM;Cespiati A;Petta S;Pelusi S;Pingitore P;Badiali S;Maggioni M;Mannisto V;Grimaudo S;Pipitone RM;Pihlajamaki J;Craxi A;Taube M;Carlsson LMS;Fargion S;Romeo S;Kozlitina J;Valenti L
通讯作者:
Valenti L
影响因子:
8.2
作者:
通讯作者:
--
影响因子:
--
作者:
Castillo-Leon E;Cioffi CE;Vos MB
通讯作者:
Vos MB